{
    "ticker": "CHW",
    "name": "Champions Oncology, Inc.",
    "description": "Champions Oncology, Inc. is a leading biotechnology company focused on transforming the treatment of cancer through its proprietary technology platform. Founded in 2010, the company specializes in developing advanced tumor models that provide valuable insights into cancer treatment and drug development. Champions Oncology's innovative approach allows for the creation of personalized cancer treatments that are tailored to individual patients' tumors, enhancing the efficacy and safety of therapeutic options. The company's flagship product, the Champions TumorGraft\u2122, enables researchers and clinicians to test and analyze the response of tumors to various therapies, thereby accelerating the drug development process and improving outcomes for cancer patients. With a commitment to advancing precision medicine, Champions Oncology collaborates with pharmaceutical companies, academic institutions, and healthcare providers to bring cutting-edge solutions to the oncology field. The company is dedicated to enhancing the understanding of cancer biology and improving treatment strategies through its research and development efforts, ultimately aiming to improve survival rates and quality of life for patients battling cancer.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Hackensack, New Jersey, USA",
    "founded": "2010",
    "website": "https://www.championsoncology.com",
    "ceo": "David Sidransky",
    "social_media": {
        "twitter": "https://twitter.com/championsonc",
        "linkedin": "https://www.linkedin.com/company/champions-oncology/"
    },
    "investor_relations": "https://www.championsoncology.com/investors",
    "key_executives": [
        {
            "name": "David Sidransky",
            "position": "CEO"
        },
        {
            "name": "Marilyn K. R. W. M. R. P. D. Z. W. A. C. M. D.",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Oncology Solutions",
            "products": [
                "Champions TumorGraft\u2122",
                "Champions Drug Response Platform"
            ]
        }
    ],
    "seo": {
        "meta_title": "Champions Oncology, Inc. | Transforming Cancer Treatment",
        "meta_description": "Discover Champions Oncology, Inc., a leader in biotechnology specializing in personalized cancer treatments through advanced tumor models. Explore our innovative solutions and commitment to precision medicine.",
        "keywords": [
            "Champions Oncology",
            "Cancer Treatment",
            "Biotechnology",
            "Personalized Medicine",
            "Tumor Models",
            "Champions TumorGraft"
        ]
    },
    "faq": [
        {
            "question": "What does Champions Oncology specialize in?",
            "answer": "Champions Oncology specializes in developing advanced tumor models for personalized cancer treatment and drug development."
        },
        {
            "question": "Who is the CEO of Champions Oncology?",
            "answer": "David Sidransky is the CEO of Champions Oncology, Inc."
        },
        {
            "question": "Where is Champions Oncology headquartered?",
            "answer": "Champions Oncology is headquartered in Hackensack, New Jersey, USA."
        },
        {
            "question": "What is the Champions TumorGraft\u2122?",
            "answer": "The Champions TumorGraft\u2122 is a proprietary technology that allows for the creation of personalized tumor models to test the response to various therapies."
        },
        {
            "question": "When was Champions Oncology founded?",
            "answer": "Champions Oncology was founded in 2010."
        }
    ],
    "competitors": [
        "CRIS",
        "SGTX",
        "CLDX",
        "EDIT"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "ABBV",
        "BMY"
    ]
}